Close Menu

NEW YORK (360Dx) – The frontier of the battle of human versus machine has reached skin cancer diagnostics with consumers increasingly using smartphone apps to help them decide whether a mole could be cancerous.

According to researchers at the University of Birmingham in the UK, however, people could be putting their health at risk by using some of the apps, and they could miss important warning signs.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.